PeptideMeter result on a Xi'an dulaglutide lot lands 2.6 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Vendors
Page 26 of 48 of this archive, newest first.
SSA declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 42% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
A tested vial is evidence about a vial
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
What changed at SWB in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
VendorInvestigate result on a Hangzhou dulaglutide lot lands 2.2 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
What a split-sample exercise can establish, and what it cannot
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
What an 8% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A supplier suspends shipping to the United Kingdom after 13 consecutive customs detentions
The route did not close because of a rule about peptides.
Medutest result on a Wuhan orforglipron lot lands 3.1 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Independent analysis puts a HJ exenatide lot at 98.4%, against 97.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
PeptideMeter result on a Hangzhou exenatide lot lands 3.5 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
Independent analysis puts a WWB exenatide lot at 98.5%, against 96.6% on the certificate
The result is unremarkable. What the report omits is not.
What a 15% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Medutest result on a Nantong orforglipron lot lands 2.6 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.